An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma
Clinical trial NCT05022901 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05022901
- Sponsor
- Delcath Systems Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2024-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.